Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Non-Current Debt (2021 - 2024)

Historic Non-Current Debt for Roivant Sciences (ROIV) over the last 4 years, with Q2 2024 value amounting to $191.5 million.

  • Roivant Sciences' Non-Current Debt rose 1788.05% to $191.5 million in Q2 2024 from the same period last year, while for Jun 2024 it was $191.5 million, marking a year-over-year increase of 1788.05%. This contributed to the annual value of $188.7 million for FY2024, which is 1796.98% up from last year.
  • As of Q2 2024, Roivant Sciences' Non-Current Debt stood at $191.5 million, which was up 1788.05% from $188.7 million recorded in Q1 2024.
  • Roivant Sciences' 5-year Non-Current Debt high stood at $204.0 million for Q4 2021, and its period low was $32.6 million during Q1 2022.
  • In the last 4 years, Roivant Sciences' Non-Current Debt had a median value of $170.3 million in 2021 and averaged $164.9 million.
  • In the last 5 years, Roivant Sciences' Non-Current Debt crashed by 8084.04% in 2022 and then soared by 39037.55% in 2023.
  • Over the past 4 years, Roivant Sciences' Non-Current Debt (Quarter) stood at $204.0 million in 2021, then decreased by 22.88% to $157.4 million in 2022, then grew by 9.3% to $172.0 million in 2023, then grew by 11.36% to $191.5 million in 2024.
  • Its Non-Current Debt stands at $191.5 million for Q2 2024, versus $188.7 million for Q1 2024 and $172.0 million for Q4 2023.